| Net Cash Provided by (Used in) Operating Activities |
$15,489,000 |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$14,981,000 |
USD |
-379% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,784,000 |
USD |
-69% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
8,966,763 |
shares |
1.1% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,276,000 |
USD |
27% |
Q2 2025 |
Q1 2026 |
| Operating Lease, Liability |
$5,216,000 |
USD |
75% |
Q3 2025 |
Q2 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$1,781,000 |
USD |
69% |
Q2 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$6,085,000 |
USD |
-66% |
Q1 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$8,569,000 |
USD |
36% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability, Current |
$750,000 |
USD |
390% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$990,000 |
USD |
167% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$1,054,000 |
USD |
190% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.07 |
pure |
|
Q3 2025 |
Q2 2026 |
| Deferred Income Tax Expense (Benefit) |
$206,000 |
USD |
-75% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$3,353,000 |
USD |
1.6% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$959,000 |
USD |
196% |
Q3 2025 |
Q2 2026 |
| Current Income Tax Expense (Benefit) |
$3,251,000 |
USD |
66% |
Q3 2025 |
Q2 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$303,000 |
USD |
-5% |
Q1 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$847,000 |
USD |
6.5% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$808,000 |
USD |
-32% |
Q1 2025 |
FY 2025 |
| Interest Expense |
$2,835,000 |
USD |
-13% |
Q3 2025 |
Q2 2026 |